Booklet 9: Routes of Admin 2 Flashcards
(23 cards)
What is the buccal and sublingual route?
Administration via oral cavity drugs are placed under the tongue or retained in the mouth
What is the purpose of the buccal and sublingual route?
Provides route for systemic administration which avoids exposure to the GI tract and liver
- most area well perfused with blood
- oral mucusa is a barrier so not highly permeable
- most substances absorbed by simple diffusion
- log P 1.6-3.3 optimal
What are the advantages of the buccal route?
- Avoids first pass effect
- Abundance of blood vessel
- Less hostile environment than the GIT
- Fast cellular recovery
- Directly and easily modify microenvironment
- Lower intersubject variability as compared with transdermal patches
- For drugs extensively metabolised in liver or unstable in the GIT
- No stratum corneum
- Can achieve sustained release
What are the disadvantages of the buccal route?
- Small absorption surface area
- Movement affects mucoadhesive systems
- Less permeable than the small intestine
- Salivation and swallowing
- Drug can’t be masked
Applications for buccal delivery
- Treat local and systemic conditions (eg. deliver Trinitrin for local treatment such as sore throat and other buccal infections
- Delivery of large, hydrophilic and unstable proteins, oligonucleotides and polysaccharide
- Alternative route for insulin delivery
Anatomy and physiology of the nose
For smelling
- ofactory membrane approx 5% of total nasal area
- heats and humidifies inspired air
- 2 mucus layers 5-20mm thick
- surface pH of mucosal cells: 7.39
- mucous layer pH: 5.5-6.5
- back 2/3 covered with cilia -> mucociliary clearance
- facilitate movement mucus from nasal cavity to the nasopharynx
3 classes of nasal delivery drugs
- Alleviation of nasal symptoms
- Alternative to injection for drugs inactivated by the GIT
- Vaccines, peptides, insulin, interferon, buserelin, nafarelin
Advantages of nasal delivery
- Avoids hepatic first pass metabolism
- Extremely rapid absorption, so only short exposure time for enzymatic activity to take place
- Level of enzymes in the tissue low, can easily saturate with the drug
Ideal properties of drug candidate
- Appropriate aq solubility to provide desired dose per nostril
- Low molecular weight (smaller better, cut off 20000 Da)
- Low dose (<25mg/dose)
- No nasal irritation
- No toxic nasal metabolites
- No offensive odors
- Suitable stability
Ideal nasal absorption enhancers
- Increase absorption if drug
- Not cause permanent damage or alteration to the tissues
- Should not be irritant or toxic, either to local or rest of body
- Be effective in small quantities
- Enhancing effect should be temporary and reversible
- Should be stable and compatible
Types of parenteral drug administration
- Intradermal
- Subcutaneous
- Intravenous
- Intramuscular
Intravenous admin
- Immediate total access to bloodstream
- Max conc reached in approx 4 mins
- Duration of action depends on dose, timescale of admin (bolus or infusion) and distribution, metabolism and excretion
- Large or small volumes can be given
Intramuscular admin
- Weak electrolytes: increased absorption w increased lipophilicity, may be binding to muscle protein
- Hydrophilic neutral compounds
- disperse from IM sites according to size
- diffuse through muscle fibres through pores of capillary walls to blood
- Pores only account for 1% of available surface of the capillary wall
- Transport through capillary wall is the rate limiting step
Subcutaneous admin
- Dissolution and absorption phases occur slower than IM as blood supply is not good
- Greater patient to patient variation in time to Cmax
- Max volume approx 1mL
Eg. Insulin, adrenalin
Intrathecal drug admin (inserted into area under spinal cord)
Admin of drugs in solution by intrathecal catheter
- > drugs to brain and spinal cord
- more invasive than IV, IM or SC
- implanted catheters and pumps have been used to reduce risk of infection on repeated puncture
Rectal drug delivery: advantages and disadvantages
- local effect
- systemic effect: when patients cannot use oral route, not stable, pH, drug not suitable for oral
- avoidance of first pass
Disadvantages: aversion (nationality dependent), slow and sometimes incomplete absorption, considerable inter- and intra- subject variation
Anatomy and physiology of rectum
- Last 150-200mm of the GIT
- Essentially hallow, flat wall surface
- Rectal mucosa normal lipoidal barrier, total surface area approx 300cm2
- Mucous volume approx 3mL
- Mucous pH approx 7.5, little buffering capacity
- 3 systemic veins -> direct to circulation
- No esterase or peptidase activity
- No active transport mechanisms
How does rectal absorption occur?
- Drug molecules enter general circulation directly (lower and middle veins) or via liver (upper vein)
- Avoidance of first pass is possible but the extent will depend on site of absorption
- Depending on vehicle, a suppository will either dissolve in rectal fluid or melt on mucous layer
Vaginal drug delivery
- Generally for local effects
- Can achieve systemic absorption
- > drug enters systemic system and avoids first pass
- > wide network of blood vessels
eg. steroids, prostaglandins, some antibiotics
How does vaginal absorption occur?
- Epithelial layer increases in thickness after puberty and menopause
- SA increased by folds and microridges
- pH decreases after puberty to 4-5
- Little fluid in the vagina
- Absorption tends to be variable
- Dosage from : pessaries
Pulmonary drug delivert
- treatment or prophylaxis of airways diseases : asthma and cystic fibrosis
- rapid onset of activity for local action
- smaller doses can be administered for oral and parenteral routes
- useful where drug is poorly absorbed orally
Systemic: large SA, abundance of capillaries
Advantages of pulmonary drug delivery
- direct admin to site of action
- smaller quantities of drug required
- rapid onset of action
- reduced side effects
Disadvantages of pulmonary drug delivery
- seeking to defeat natural body defense
- demands on patient (educated)
- deposition is technically inefficient